Hsa_circ_0056558 regulates cyclin-dependent kinase 6 by sponging microRNA-1290 to suppress the proliferation and differentiation in ankylosing spondylitis

References

• van der Heijde D, Braun J, Deodhar A, et al. Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology (Oxford). 2019;58(3):388–400.
   PubMed Web of Science ®Google Scholar
• Chee MM, Sturrock RD. Ankylosing spondylitis. Scottish medical journal. Scott Med J. 2007;52(4):32–35.
   PubMed Web of Science ®Google Scholar
• Wen C, Zheng Z, Shao T, et al. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome Biol. 2017;18(1):142.
   PubMedGoogle Scholar
• Deodhar AA, Dougados M, Baeten DL, et al. Effect of secukinumab on patient-reported outcomes in patients with active ankylosing spondylitis: a phase III randomized trial (MEASURE 1). Arthritis Rheumatol. 2016;68(12):2901–2910.
   PubMed Web of Science ®Google Scholar
• Garg N, van den Bosch F, Deodhar A. The concept of spondyloarthritis: where are we now? Best Pract Res Clin Rheumatol. 2014;28(5):663–672.
   PubMed Web of Science ®Google Scholar
• Zou YC, Yang XW, Yuan SG, et al. Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro. Connect Tissue Res. 2016;57(3):200–211.
   PubMed Web of Science ®Google Scholar
• Ma C, Wen B, Zhang Q, et al. Emodin induces apoptosis and autophagy of fibroblasts obtained from patient with ankylosing spondylitis. Drug Des Devel Ther. 2019;13:601–609.
   PubMed Web of Science ®Google Scholar
• Baeten D, Østergaard M, Wei JC, et al. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann Rheum Dis. 2018;77(9):1295–1302. Sep
   PubMed Web of Science ®Google Scholar
• Osman MS, Maksymowych WP. An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis. Expert Rev Clin Immunol. 2017;13(2):125–131.
   PubMed Web of Science ®Google Scholar
• Greene J, Baird AM, Brady L, et al. Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci. 2017;4:38.
   PubMed Web of Science ®Google Scholar
• Ciechomska M, Bonek K, Merdas M, et al. Changes in MiRNA-5196 expression as a potential biomarker of anti-TNF-α therapy in rheumatoid arthritis and ankylosing spondylitis patients. Arch Immunol Ther Exp (Warsz)). 2018;66(5):389–397.
   PubMed Web of Science ®Google Scholar
• Li Z, Wong SH, Shen J, et al. The role of MicroRNAS in ankylosing spondylitis. Medicine (Baltimore)). 2016;95(14):e3325.
   PubMed Web of Science ®Google Scholar
• Li H, Lan M, Liao X, et al. Circular RNA cir-ITCH promotes osteosarcoma migration and invasion through cir-ITCH/miR-7/EGFR pathway. Technol Cancer Res Treat. 2020;19:1533033819898728.
   Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428–442.
   PubMed Web of Science ®Google Scholar
• Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32(5):309–316.
   PubMed Web of Science ®Google Scholar
• Li B, Li N, Zhang L, et al. Hsa_circ_0001859 regulates ATF2 expression by functioning as an MiR-204/211 sponge in human rheumatoid arthritis. J Immunol Res. 2018;2018:9412387.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang Y, Zhang Y, et al. CircRNA hsa_circ_0005105 upregulates NAMPT expression and promotes chondrocyte extracellular matrix degradation by sponging miR-26a. Cell Biol Int. 2017;41(12):1283–1289., Dec
   PubMed Web of Science ®Google Scholar
• Joseph NA, Chiou SH, Lung Z, et al. The role of HGF-MET pathway and CCDC66 cirRNA expression in EGFR resistance and epithelial-to-mesenchymal transition of lung adenocarcinoma cells. J Hematol Oncol. 2018; May 3111(1):74.
   PubMedGoogle Scholar
• Li Z, Yuan B, Pei Z, et al. Circ_0136474 and MMP-13 suppressed cell proliferation by competitive binding to miR-127-5p in osteoarthritis. J Cell Mol Med. 2019;23(10):6554–6564.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang X, Chen Y, et al. The down-regulation of hsa_circ_0012919, the sponge for miR-125a-3p, contributes to DNA methylation of CD11a and CD70 in CD4(+) T cells of systemic lupus erythematous. Clin Sci (London, England: 1979). 2018;132(21):2285–2298.
   PubMed Web of Science ®Google Scholar
• Uras IZ, Maurer B, Nivarthi H, et al. CDK6 coordinates JAK2V617F mutant MPN via NF-κB and apoptotic networks . Blood. 2019;133(15):1677–1690.
   PubMed Web of Science ®Google Scholar
• Sun H, Huang Z, Wu P, et al. CDK6 and miR-320c Co-regulate chondrocyte catabolism through NF-κB signaling pathways. Cell Physiol Biochem. 2018;51(2):909–923.
   PubMedGoogle Scholar
• Kollmann K, Heller G, Schneckenleithner C, et al. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell. 2013;24(2):167–181.
   PubMed Web of Science ®Google Scholar
• Uras IZ, Scheicher RM, Kollmann K, et al. Cdk6 contributes to cytoskeletal stability in erythroid cells. Haematologica. 2017;102(6):995–1005.
   PubMed Web of Science ®Google Scholar
• Patop IL, Wüst S, Kadener S. Past, present, and future of circRNAs. Embo J. 2019;38(16):e100836.
   PubMed Web of Science ®Google Scholar
• Patop IL, Kadener S. circRNAs in cancer. Curr Opin Genet Dev. 2018;48:121–127.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhang R, Zhang X, et al. Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of atherosclerosis in rabbits. Aging (Albany NY)). 2018;10(9):2266–2283.
   PubMedGoogle Scholar
• Floris G, Zhang L, Follesa P, et al. Regulatory role of circular RNAs and neurological disorders. Mol Neurobiol. 2017;54(7):5156–5165.
   PubMed Web of Science ®Google Scholar
• Ye YL, Yin J, Hu T, et al. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients. WJG. 2019;25(41):6273–6288.
   PubMed Web of Science ®Google Scholar
• Zheng F, Yu X, Huang J, et al. Circular RNA expression profiles of peripheral blood mononuclear cells in rheumatoid arthritis patients, based on microarray chip technology. Mol Med Rep. 2017;16(6):8029–8036.
   PubMed Web of Science ®Google Scholar
• Zhu H, Hu Y, Wang C, et al. CircGCN1L1 promotes synoviocyte proliferation and chondrocyte apoptosis by targeting miR-330-3p and TNF-α in TMJ osteoarthritis. Cell Death Dis. 2020;11(4):284.
   PubMed Web of Science ®Google Scholar
• Luo Q, Zhang L, Li X, et al. Identification of circular RNAs hsa_circ_0044235 in peripheral blood as novel biomarkers for rheumatoid arthritis. Clin Exp Immunol. 2018;194(1):118–124.
   PubMed Web of Science ®Google Scholar
• Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs' action through miRNA editing. IJMS. 2019;20(24):6249.
   Google Scholar
• Qin X, Zhu B, Jiang T, et al. miR-17-5p regulates heterotopic ossification by targeting ANKH in ankylosing spondylitis. Mol Ther Nucleic Acids. 2019;18:696–707.
   PubMedGoogle Scholar
• Xia Y, Chen K, Zhang MH, et al. MicroRNA-124 involves in ankylosing spondylitis by targeting ANTXR2. Mod Rheumatol. 2015;25(5):784–789.
   PubMed Web of Science ®Google Scholar
• Tang SL, Huang QH, Wu LG, et al. MiR-124 regulates osteoblast differentiation through GSK-3β in ankylosing spondylitis. Eur Rev Med Pharmacol Sci. 2018;22(20):6616–6624.
   PubMed Web of Science ®Google Scholar
• Chen L, Al-Mossawi MH, Ridley A, et al. miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis. Ann Rheum Dis. 2017;76(3):620–625.
   PubMed Web of Science ®Google Scholar
• Dai N, Zhong ZY, Cun YP, et al. Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA. Neoplasma. 2013;60(4):384–394.
   PubMed Web of Science ®Google Scholar
• Sun H, Hu S, Zhang Z, et al. Expression of exosomal microRNAs during chondrogenic differentiation of human bone mesenchymal stem cells. J Cell Biochem. 2019;120(1):171–181.
   PubMed Web of Science ®Google Scholar
• Ng PC, Chan KYY, Yuen TP, et al. Plasma miR-1290 is a novel and specific biomarker for early diagnosis of necrotizing enterocolitis-biomarker discovery with prospective cohort evaluation. J Pediatr. 2019;205:83–90 e10.
   PubMed Web of Science ®Google Scholar
• Handschick K, Beuerlein K, Jurida L, et al. Cyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-κB-dependent gene expression. Mol Cell. 2014;53(2):193–208.
   PubMed Web of Science ®Google Scholar
• Scheicher R, Hoelbl-Kovacic A, Bellutti F, et al. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. Blood. 2015;125(1):90–101.
   PubMed Web of Science ®Google Scholar
• Buss H, Handschick K, Jurrmann N, et al. Cyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expression. PloS One. 2012;7(12):e51847.
   PubMed Web of Science ®Google Scholar
• Obligado SH, Ibraghimov-Beskrovnaya O, Zuk A, et al. CDK/GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases. Kidney Int. 2008;73(6):684–690.
   PubMed Web of Science ®Google Scholar
• Infante JR, Cassier PA, Gerecitano JF, et al. A phase I study of the cyclin-dependent kinase 4/6 inhibitor ribociclib (LEE011) in patients with advanced solid tumors and lymphomas. Clin Cancer Res. 2016;22(23):5696–5705.
   PubMed Web of Science ®Google Scholar
• Brand M, Jiang B, Bauer S, et al. Homolog-selective degradation as a strategy to probe the function of CDK6 in AML. Cell Chem Biol. 2019;26(2):300–306 e9.
   PubMed Web of Science ®Google Scholar
• Zelová H, Hošek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res. 2013;62(7):641–651.
   PubMed Web of Science ®Google Scholar
• Del Giudice M, Gangestad SW. Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun. 2018;70:61–75.
   PubMed Web of Science ®Google Scholar
• Castaño Z, San Juan BP, Spiegel A, et al. IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nat Cell Biol. 2018;20(9):1084–1097.
   PubMed Web of Science ®Google Scholar
• Blüml S, Scheinecker C, Smolen JS, et al. Targeting TNF receptors in rheumatoid arthritis. Int Immunol. 2012;24(5):275–281.
   PubMed Web of Science ®Google Scholar
• Radner H, Aletaha D. Anti-TNF in rheumatoid arthritis: an overview. Wien Med Wochenschr. 2015;165(1-2):3–9.
   PubMed Web of Science ®Google Scholar
• Psarelis S, Hajineocli APD, Hadjicosta E, et al. Is secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barré syndrome after anti-TNF-α treatment? Case report and literature review. Clin Rheumatol. 2017;36(5):1197–1199.
   PubMed Web of Science ®Google Scholar
• Zou YC, Yan LM, Gao YP, et al. miR-21 may act as a potential mediator between inflammation and abnormal bone formation in ankylosing spondylitis based on TNF-α concentration-dependent manner through the JAK2/STAT3 pathway. Dose Response. 2020;18(1):1559325819901239.
   Web of Science ®Google Scholar
• Dai C, Chung IJ, Krantz SB. In human immature BFU-E tumor necrosis factor-alpha not only downregulates CDK6 but also directly produces apoptosis which is prevented by stem cell factor. Exp Hematol. 2004;32(10):911–917.
   PubMed Web of Science ®Google Scholar
• Palomo J, Dietrich D, Martin P, et al. The interleukin (IL)-1 cytokine family-balance between agonists and antagonists in inflammatory diseases. Cytokine. 2015;76(1):25–37.
   PubMed Web of Science ®Google Scholar
• Jani PH, Gibson MP, Liu C, et al. Transgenic expression of Dspp partially rescued the long bone defects of Dmp1-null mice. Matrix Biol. 2016;52-54:95–112.
   PubMed Web of Science ®Google Scholar
• Nossent JC, Sagen-Johnsen S, Bakland G. IL-1A gene variation in relation to cytokine levels and clinical characteristics in ankylosing spondylitis. Eur J Rheumatol. 2019;6(2):67–70.
   PubMed Web of Science ®Google Scholar
• Wang H, He P, Pan H, et al. Circular RNA circ-4099 is induced by TNF-α and regulates ECM synthesis by blocking miR-616-5p inhibition of Sox9 in intervertebral disc degeneration. Exp Mol Med. 2018;50(4):27.
   Google Scholar
• Yang QY, Yang KP, Li ZZ. MiR-22 restrains proliferation of rheumatoid arthritis by targeting IL6R and may be concerned with the suppression of NF-κB pathway. Kaohsiung J Med Sci. 2020;36(1):20–26.
   PubMed Web of Science ®Google Scholar
• Li G, Qiu Z. Deletion of miR-15 protects against rheumatoid arthritis via deregulating its target gene BCL2L2 and repressing NF-κB pathway. Ann Clin Lab Sci. 2019;49(5):581–589.
   PubMed Web of Science ®Google Scholar
• Atzeni F, Nucera V, Masala IF, et al. Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab. Pharmacol Res. 2019;149:104402.
   PubMed Web of Science ®Google Scholar
• Rabelo CF, Baptista TSA, Petersen LE, et al. Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis. OARRR. 2018;10:21–25.
   Google Scholar
• Huang Z, Cao Y, Zhou M, et al. Hsa_circ_0005519 increases IL-13/IL-6 by regulating hsa-let-7a-5p in CD4(+) T cells to affect asthma. Clin Exp Allergy. 2019;49(8):1116–1127.
   PubMed Web of Science ®Google Scholar
• Ye C, Zhang W, Hang K, et al. Extracellular IL-37 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the PI3K/AKT signaling pathway. Cell Death Dis. 2019;10(10):753.
   PubMedGoogle Scholar
• Zou YC, Yang XW, Yuan SG, et al. Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro. Drug Des Devel Ther. 2016;10:933–948.
   PubMed Web of Science ®Google Scholar
• Gai X, Li L. Overexpression of long noncoding RNAs (lncRNA) NF-κβ-interacting long noncoding RNA (NKILA) in ankylosing spondylitis is correlated with transforming growth factor β1 (TGF-β1), active disease and predicts length of treatment. Med Sci Monit. 2019;25:4244–4249.
   PubMed Web of Science ®Google Scholar
• Roozbehkia M, Mahmoudi M, Aletaha S, et al. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB signaling pathway in ankylosing spondylitis patients. Int Immunopharmacol. 2017;52:191–196.
   PubMed Web of Science ®Google Scholar
• Sun X, Chen L, He Z. PI3K/Akt-Nrf2 and anti-inflammation effect of macrolides in chronic obstructive pulmonary disease. Curr Drug Metab. 2019;20(4):301–304.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang L, Liu Y, et al. Circ-8073 regulates CEP55 by sponging miR-449a to promote caprine endometrial epithelial cells proliferation via the PI3K/AKT/mTOR pathway. Biochim Biophys Acta Mol Cell Res. 2018;1865(8):1130–1147.
   PubMed Web of Science ®Google Scholar
• Yan H, Wang S, Yu H, et al. Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells. Pharmacology. 2013;92(3-4):167–174.
   PubMed Web of Science ®Google Scholar
• Bonelli MA, Digiacomo G, Fumarola C, et al. Combined inhibition of CDK4/6 and PI3K/AKT/mTOR pathways induces a synergistic anti-tumor effect in malignant pleural mesothelioma cells. Neoplasia. 2017;19(8):637–648.
   PubMed Web of Science ®Google Scholar
• Mitchell JP, Carmody RJ. NF-κB and the transcriptional control of inflammation. Int Rev Cell Mol Biol. 2018;335:41–84.
   PubMed Web of Science ®Google Scholar
• Mothes J, Busse D, Kofahl B, et al. Sources of dynamic variability in NF-κB signal transduction: a mechanistic model. Bioessays. 2015;37(4):452–462.
   PubMed Web of Science ®Google Scholar
• Liu B, Sun L, Liu Q, et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. Cancer Cell. 2015;27(3):370–381.
   PubMed Web of Science ®Google Scholar
• Morotti A, Crivellaro S, Panuzzo C, et al. IκB-α: At the crossroad between oncogenic and tumor-suppressive signals. Oncol Lett. 2017;13(2):531–534.
   PubMed Web of Science ®Google Scholar
• Eggert M, Seeck U, Semmler M, et al. An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration. Rheumatol Int. 2007;27(9):841–846.
   PubMed Web of Science ®Google Scholar
• Cheng J, Liu Q, Hu N, et al. Downregulation of hsa_circ_0068087 ameliorates TLR4/NF-κB/NLRP3 inflammasome-mediated inflammation and endothelial cell dysfunction in high glucose conditioned by sponging miR-197. Gene. 2019;709:1–7.
   PubMed Web of Science ®Google Scholar